The cranial neural crest gives rise to most of the skeletal tissues of the
skull. Matrix-mediated tissue interactions have been implicated in the skel
etogenic differentiation of crest cells, but little is known of the role th
at growth factors might play in this process. The discovery that mutations
in fibroblast growth factor receptors (FGFRs) cause the major craniosynosto
sis syndromes implicates FGF-mediated signalling in the skeletogenic differ
entiation of the cranial neural crest. We now show that, in vitro, mesencep
halic neural crest cells respond to exogenous FGF2 in a dose-dependent mann
er, with 0.1 and 1 ng/ml causing enhanced proliferation, and 10 ng/ml induc
ing cartilage differentiation. In longer-term cultures, both endochondral a
nd membrane bone are formed. FGFR1, FGFR2 and FGFR3 are all detectable by i
mmunohistochemistry in the mesencephalic region, with particularly intense
expression at the apices of the neural folds from which the neural crest ar
ises. FGFRs are also expressed by subpopulations of neural crest cells in c
ulture. Collectively, these findings suggest that FGFs are involved in the
skeletogenic differentiation of the cranial neural crest.